Bleichroeder LP

Holdings History for Evoke Pharma, Inc. - Common Shares (EVOK)

Symbol: EVOK on Nasdaq
Investment type: Equity / Common Shares
Latest Disclosed Shares Owned: 158,058 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Bleichroeder LP ownership in Evoke Pharma, Inc. Common Shares (EVOK)

24 Mar 2025 - Bleichroeder LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 158,058 shares of Evoke Pharma, Inc. Common Shares (EVOK). This represents 10% ownership of the company. In their previous filing dated 21 Mar 2025, Bleichroeder LP had reported owning 849,367 shares, indicating a decrease of +81%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Bleichroeder LP	10%	0%	$63,223	158,058	-691,309	-81%	$0.40	13G/A	24 Mar 2025	24 Mar 2025, 18:47
Bleichroeder LP	10%		$339,747	849,367			$0.40	13G/A	19 Mar 2025	21 Mar 2025, 19:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0.13%	$0	0	-825,000	-100%		Q3 2024
30 Jun 2024	0.13%	0%	$436,425	825,000	0		$0.53	Q2 2024
31 Mar 2024	0.13%	+0.13%	$503,250	825,000	+825,000	NEW	$0.61	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.